By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Lexicon Pharmaceuticals, Inc. 

8800 Technology Forest Place

The Woodlands  Texas  77381-1160  U.S.A.
Phone: 281-863-3000 Fax: 281-863-8088



Company News
Lexicon Pharma (LXRX) To Present At The Stifel 2015 Healthcare Conference And The Jefferies and Co. 2015 Global Healthcare Conference 11/12/2015 10:46:42 AM
Lexicon Pharma (LXRX) Reports 3rd Quarter Financial Results And Discusses Collaboration With Sanofi (SNY) For Sotagliflozin 11/6/2015 7:51:09 AM
Lexicon Pharma (LXRX) To Report Third Quarter 2015 Financial Results On November 6, 2015 11/6/2015 6:47:20 AM
Another Deal for Sanofi (SNY) with $1.7 Billion Lexicon Pharma (LXRX) Diabetes Pact 11/6/2015 5:33:04 AM
Cancer Patients Treated With Lexicon Pharma (LXRX)'s Telotristat Etiprate Report Improved Function And Well-Being 10/19/2015 9:49:56 AM
Lexicon Pharma (LXRX) Announces Telotristat Etiprate Data To Be Presented At North American Neuroendocrine Tumor Society Annual Symposium 10/9/2015 7:34:22 AM
Lexicon Pharma (LXRX)'s Telotristat Etiprate Shows Clinical Benefit In Treating Carcinoid Syndrome In Cancer Patients When Added To Standard Of Care 9/29/2015 6:34:42 AM
Media Alert: Lexicon Pharma (LXRX) To Discuss Complete Results Of Pivotal Phase 3 TELESTAR Study 9/28/2015 11:45:47 AM
Lexicon Pharma (LXRX) Announces Sotagliflozin Data To Be Presented At European Association For The Study Of Diabetes 9/8/2015 10:02:55 AM
Lexicon Pharma (LXRX) Announces Telotristat Etiprate Data To Be Presented At European Cancer Congress 8/26/2015 7:50:23 AM